Yazan Ayman Abuzenah

Yazan Ayman Abuzenah

Auto-generated profile, based on publicly available information

Yazan Ayman Abuzenah

Pediatric Department, King Hussein Foundation, Amman, Jordan

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2026 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
RSRola Saqan
Rola Saqan
MTMohammad Tayyem
Mohammad Tayyem
MAMohammad Alathirah
Mohammad Alathirah
AJAsaad Mohammad Jarrar
Asaad Mohammad Jarrar
RMReem Mohammad Muhsen
Reem Mohammad Muhsen
YAYazan Ayman Abuzenah
Yazan Ayman Abuzenah
Purpose: This study used data collected nine years apart (2014 and 2023) to compare the prevalence of Escherichia coli that produces extended-spectrum β-lactamase (ESBL) among patients with urinary tract infections at a tertiary care center. Additionally, it aimed to assess how ESBL prevalence varied by gender and age group. Patients and Methods: Urine culture data from 2014 and 2023 were used in this two-point cross-sectional investigation. Data on demographics and microbiology were retrieved and examined. Chi-square tests were used in conjunction with prevalence ratios and phi coefficient tests for statistical comparison. Results: The overall prevalence of ESBL-positive E. coli in 2500 patients rose from 43.7% to 58.9% between 2014 and 2023. The rise was even more noticeable in male patients PR = 1.50 and pediatric patients 41% to 65.4%, PR = 1.55. All age groups showed statistically significant increases in ESBL-positive, however, the level of statistical power varied. Conclusion: There has been a rise in ESBL-producing E. coli UTIs over the previous ten years, particularly in male children. These results emphasize how urgent it is to improve responsible antibiotic use must be improved to reduce future antimicrobial resistance.